临床护理对不稳定型心绞痛患者焦虑抑郁情绪的影响观察被引量：10

下载PDF

导出

摘要目的观察临床护理干预对不稳定型心绞痛患者焦虑和抑郁情绪的影响,为临床实践提供参考与指导。方法将76例不稳定型心绞痛患者随机划分为护理研究组与护理对照组,对照组患者实施常规的对症护理措施,研究组患者实施以心理护理为主导的综合护理措施。结果经分组实施临床护理后,护理对照组患者的焦虑自评量表(SAS)得分和抑郁自评量表(SDS)得分明显高于护理研究组,且对比差异具有统计学意义,这说明护理对照组患者的焦虑抑郁情绪更加严重,护理研究组患者的心理更加健康。结论对不稳定型心绞痛患者实施以心理护理为主导的综合护理措施,可有效改善患者的焦虑抑郁情绪,提高患者的心理健康水平,值得加强临床推广与实践。

作者孙炳坤

机构地区辽宁省锦州市第二医院

出处《中国医药指南》 2016年第2期213-214,共2页 Guide of China Medicine

关键词不稳定型心绞痛心理护理焦虑抑郁

分类号 R473.5 [医药卫生—护理学] R473.74 [医药卫生—临床医学]

引文网络
相关文献

参考文献3

1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2136
2葛均波,徐永健主编..内科学[M].北京:人民卫生出版社,2013:952.
3朱芸.护理干预对不稳定型心绞痛患者情绪影响的护理效果[J].中国现代药物应用,2013,7(17):182-183. 被引量：13

二级参考文献27

1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量：193
2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374. 被引量：1
3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840. 被引量：1
4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176. 被引量：1
5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339. 被引量：1
6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502. 被引量：1
7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533. 被引量：1
8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924. 被引量：1
9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505. 被引量：1
10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497. 被引量：1